TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.

Lipika Goyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.